Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock

Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation

March 16, 2020
Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …

News
celltrion1

FDA greenlights Celltrion HIV drug manufacturing facility in South Korea

March 16, 2020
Manufacturing and Production, Sales and Marketing FDA, celltrion, coronavirus, pharma

South Korean biopharma firm Celltrion has revealed that one of its key manufacturing facilities has been given the all-clear by …

News
5378943799_deb47ba367_b

Numerous sporting events suspended across the UK, after staff and players test positive for COVID-19

March 13, 2020
Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Sporting events across the UK have been postponed as measures are taken to halt the spread of the coronavirus. Rugby …

News
shutterstock_38078521

AstraZeneca’s cediranib combo misses main goal in platinum-sensitive relapsed ovarian cancer

March 13, 2020
Medical Communications, Research and Development AstraZeneca, cediranib, lynparza, pharma, trial failure

Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 13, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Coronavirus Wuhan, HIV, HIV/AIDS, UK Coronavirus, coronavirus

HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …

News

Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia

March 13, 2020
Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma

The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …

News
Photo by Chatham House

UK Government criticised for not enacting social distancing measures to combat coronavirus

March 13, 2020
Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

The UK government has come under fire from health experts and former cabinet ministers for its strategy in fighting the …

News
merck-keytruda

Keytruda rejected for NHS use for bladder cancer, will be removed from the Cancer Drugs Fund

March 12, 2020
Sales and Marketing Cancer, Kidney cancer, MSD, NHS, NICE, blader cancer, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has been knocked back by NICE for use on the NHS as a treatment for …

News
7424861282_ee152c7c60_b

Iran foreign ministry accuses US of blocking medicine deliveries

March 12, 2020
Business Services Iran, Iran Trump, Trump Iran

A spokesperson from the Iranian foreign ministry has accused the US of refusing to deliver medicine to the country. US …

News
46451130962_d151b497d6_b

Trump suspends all travel from Europe to US as coronavirus continues to spread

March 12, 2020
Business Services American coronavirus, Chinese Coronavirus, UK Coronavirus, US Coronavirus, Wuhan Coronavirus, wuhan coronavirus.

Last night, President Donald Trump announced significant measures to deal with the increasing threat of the coronavirus. From Friday, the …

News
teva_copy

Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine

March 12, 2020
Sales and Marketing NICE, Teva, ajovy, migraine, pharma

NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …

News
4353113087_4d19c3a402_b

Bristol-Myers Squibb liver cancer drug combo gets FDA approval

March 12, 2020
Business Services Bristol; Myer Squibb, FDA, FDA BSM, FDA approvals

The FDA announced on Wednesday that it approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy to treat patients with hepatocellular …

News
fda2outsideweb

FDA halts overseas inspections over coronavirus concerns

March 11, 2020
Research and Development, Sales and Marketing FDA, US, approvals, pharma

The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …

News

Ameluz approved by European Commission for treatment for actinic keratosis

March 11, 2020
Research and Development EC, EMA, Europe, Lesions

Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …

News
takeda_usa_pharmaceuticals_u

Takeda’s Ninlaro combo fails to hit main goal in newly diagnosed, transplant ineligible multiple myeloma

March 11, 2020
Research and Development, Sales and Marketing Ninlaro, Takeda, multiple myeloma, pharma

Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …

News

A man from London becomes second person to be cured of HIV

March 11, 2020
Research and Development HIV, HIV AIDS, HIV Drug, HIV cure, HIV/AIDS, anti-HIV

Adam Castillejo is the second man to be cured of HIV, after being free of the virus for more than …

News
mitchell_web

Data science firm Genomics Plc names new Chief Strategy Officer

March 10, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma

Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …

Appointment
conference_peach

The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns

March 10, 2020
Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology

The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …

News
boehringer_biberach_germany_copy

Boehringer’s TKI inhibitor Ofev gets FDA approval for chronic fibrosing interstitial lung diseases with a progressive phenotype

March 10, 2020
Manufacturing and Production, Sales and Marketing Boehringer, FDA, ofev, pharma

The FDA has green-lit Boehringer Ingelheim’s multi-targeted tyrosine kinase inhibitor Ofev (nintedanib) in the treatment of chronic fibrosing interstitial lung …

News
48610088067_59be70df49_b

Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women

March 10, 2020
Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin

Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025